CN106110011A - 一种散瘀消肿的药物 - Google Patents
一种散瘀消肿的药物 Download PDFInfo
- Publication number
- CN106110011A CN106110011A CN201610577885.0A CN201610577885A CN106110011A CN 106110011 A CN106110011 A CN 106110011A CN 201610577885 A CN201610577885 A CN 201610577885A CN 106110011 A CN106110011 A CN 106110011A
- Authority
- CN
- China
- Prior art keywords
- grams
- swelling
- medicine
- blood stasis
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 49
- 239000008280 blood Substances 0.000 title claims abstract description 49
- 239000003814 drug Substances 0.000 title claims abstract description 41
- 230000008961 swelling Effects 0.000 title claims abstract description 31
- 230000001737 promoting effect Effects 0.000 claims abstract description 29
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims abstract description 21
- 235000007351 Eleusine Nutrition 0.000 claims abstract description 20
- 241000209215 Eleusine Species 0.000 claims abstract description 20
- 230000017531 blood circulation Effects 0.000 claims abstract description 16
- 208000004880 Polyuria Diseases 0.000 claims abstract description 11
- 230000035619 diuresis Effects 0.000 claims abstract description 11
- 239000002994 raw material Substances 0.000 claims description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 8
- 239000000919 ceramic Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 5
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 5
- 239000000203 mixture Substances 0.000 claims description 5
- 210000003205 muscle Anatomy 0.000 claims description 5
- 238000012216 screening Methods 0.000 claims description 5
- 239000002023 wood Substances 0.000 claims description 5
- 244000025254 Cannabis sativa Species 0.000 claims description 3
- 241000736199 Paeonia Species 0.000 claims 2
- 235000006484 Paeonia officinalis Nutrition 0.000 claims 2
- 241000283690 Bos taurus Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 14
- 208000002193 Pain Diseases 0.000 abstract description 12
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 210000004185 liver Anatomy 0.000 abstract description 9
- 230000001717 pathogenic effect Effects 0.000 abstract description 9
- 231100000614 poison Toxicity 0.000 abstract description 8
- 230000008901 benefit Effects 0.000 abstract description 6
- 239000003440 toxic substance Substances 0.000 abstract description 6
- 206010007247 Carbuncle Diseases 0.000 abstract description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 4
- 208000005392 Spasm Diseases 0.000 abstract description 4
- 208000025865 Ulcer Diseases 0.000 abstract description 4
- 231100000252 nontoxic Toxicity 0.000 abstract description 4
- 230000003000 nontoxic effect Effects 0.000 abstract description 4
- 208000026435 phlegm Diseases 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 238000009169 immunotherapy Methods 0.000 abstract description 3
- 244000052769 pathogen Species 0.000 abstract description 3
- 239000012530 fluid Substances 0.000 abstract description 2
- 241000411851 herbal medicine Species 0.000 abstract description 2
- 230000001047 pyretic effect Effects 0.000 abstract description 2
- 230000000630 rising effect Effects 0.000 abstract description 2
- 230000001225 therapeutic effect Effects 0.000 abstract description 2
- 231100000419 toxicity Toxicity 0.000 abstract description 2
- 230000001988 toxicity Effects 0.000 abstract description 2
- 208000006820 Arthralgia Diseases 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 5
- 210000000952 spleen Anatomy 0.000 description 5
- 238000005728 strengthening Methods 0.000 description 5
- 206010011224 Cough Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 239000000686 essence Substances 0.000 description 4
- 208000008035 Back Pain Diseases 0.000 description 3
- 208000005171 Dysmenorrhea Diseases 0.000 description 3
- 206010013935 Dysmenorrhoea Diseases 0.000 description 3
- 206010019233 Headaches Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 208000008930 Low Back Pain Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 231100000869 headache Toxicity 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000008736 traumatic injury Effects 0.000 description 3
- WQZGKKKJIJFFOK-SVZMEOIVSA-N (+)-Galactose Chemical compound OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-SVZMEOIVSA-N 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 206010019345 Heat stroke Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000004087 circulation Effects 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000003172 expectorant agent Substances 0.000 description 2
- 230000003419 expectorant effect Effects 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000007096 poisonous effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 235000015961 tonic Nutrition 0.000 description 2
- 230000001256 tonic effect Effects 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 206010044008 tonsillitis Diseases 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 1
- 235000003826 Artemisia Nutrition 0.000 description 1
- 240000006891 Artemisia vulgaris Species 0.000 description 1
- 235000003261 Artemisia vulgaris Nutrition 0.000 description 1
- 206010063659 Aversion Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 206010058019 Cancer Pain Diseases 0.000 description 1
- 206010010356 Congenital anomaly Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010011732 Cyst Diseases 0.000 description 1
- 201000005171 Cystadenoma Diseases 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- 206010052369 Encephalitis lethargica Diseases 0.000 description 1
- 208000010228 Erectile Dysfunction Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000037319 Hepatitis infectious Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007180 Sunstroke Diseases 0.000 description 1
- 206010042674 Swelling Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000009052 artemisia Nutrition 0.000 description 1
- 230000002917 arthritic effect Effects 0.000 description 1
- 206010003246 arthritis Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 238000005202 decontamination Methods 0.000 description 1
- 230000003588 decontaminative effect Effects 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 206010013990 dysuria Diseases 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- DNJIEGIFACGWOD-UHFFFAOYSA-N ethanethiol Chemical compound CCS DNJIEGIFACGWOD-UHFFFAOYSA-N 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000010037 flour treatment agent Nutrition 0.000 description 1
- 235000003132 food thickener Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 231100000753 hepatic injury Toxicity 0.000 description 1
- 208000005252 hepatitis A Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002068 microbial inoculum Substances 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 206010029410 night sweats Diseases 0.000 description 1
- 230000036565 night sweats Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 206010037844 rash Diseases 0.000 description 1
- 235000020995 raw meat Nutrition 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 230000002522 swelling effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 231100000611 venom Toxicity 0.000 description 1
- 210000001048 venom Anatomy 0.000 description 1
- 201000002498 viral encephalitis Diseases 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/282—Artemisia, e.g. wormwood or sagebrush
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
一种散瘀消肿的药物，属于中草药加工的技术领域。采用香茶菜、白芍、牛筋草、黄花倒水莲、平地木、玄精石、沙蒿籽和EM原露等制备而成。采用的中草药物无毒，安全可靠，内服外用针对性治疗瘀血肿痛，痈疮肿毒，发热肿痛等病症，疗效显著，使用方便简单易行。香茶菜和牛筋草清热利湿，活血通络散瘀，解毒消肿，祛痰开窍，化瘀镇痛。白芍养血和营，缓急止痛，敛阴平肝与玄精石清热，益精气，去血热，除风冷邪气。白芍配伍香茶菜、牛筋草能助于增强清热利湿，活血通络散瘀，解毒消肿的功效。白芍能抑阳平肝,阴阳平衡，祛除热毒病邪，顺通血脉，独特的功能在配伍中相互相生促进药物治愈的良效，快速得到满意的治疗效果。
Description
技术领域
本发明属于中草药加工的技术领域，尤其涉及一种散瘀消肿的药物。
背景技术
我国地大物博，几千年以来特别擅长中医中药的医治方法，取得了惊人的疗效。对于平时常见的肿痛问题，很多能药到病除。在西医，治疗肿痛疾病则是采用抗生素之类药物，或静脉吊针等法，经常使用对人体有一定的潜在损害。本申请采用长期实践使用的各种中草药治疗瘀血肿痛、痈疮肿毒及瘀积肿胀、囊肿瘤等症，收到了满意的疗效。
发明内容
一种散瘀消肿的药物，采用香茶菜、白芍、牛筋草、黄花倒水莲、平地木、玄精石、沙蒿籽和EM原露等制备而成。采用的中草药物无毒，安全可靠，内服外用针对性治疗瘀血肿痛，痈疮肿毒，发热肿痛等病症，疗效显著，使用方便简单易行。
本发明的技术措施
一种散瘀消肿的药物，采用原料为：香茶菜40-120克、白芍40-120克、牛筋草25-70克、黄花倒水莲30-80克、平地木20-60克、玄精石16-50克、沙蒿籽适量、EM原露按需使用。
将香茶菜、白芍、牛筋草、玄精石、黄花倒水莲和平地木筛选、净化，粉碎，放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬25-40分钟。
打开锅盖滤出药汁，晾凉至常温后加入适量EM原露拌匀，即成为清热利湿，活血散瘀消肿的内服药物。
将药渣倒在陶瓷盘中，在常温下加入适量沙蒿籽和适量EM原露拌匀，成为清热利湿，活血散瘀消肿的外用药物。
注： 1. EM原露为微生物群体，宜于常温以下使用或保存。
本发明的有益效果
1.香茶菜和牛筋草清热利湿，活血通络散瘀，解毒消肿，祛痰开窍，化瘀镇痛。牛筋草和黄花倒水莲能活血补气，行血长力强筋骨，驱风利湿散瘀止血，滋补强壮散瘀消肿，补脾益肾滋阴降火，平地木化痰止咳，利湿，活血，辅助治疗痰聚结的肿胀。诸药合用既清热散瘀消肿，又能滋阴补体。
2.白芍养血和营，缓急止痛，敛阴平肝与玄精石清热，益精气，去血热，除风冷邪气。白芍配伍香茶菜、牛筋草能助于增强清热利湿，活血通络散瘀，解毒消肿的功效。白芍能抑阳平肝,阴阳平衡，祛除热毒病邪，顺通血脉，独特的功能在配伍中相互相生促进药物治愈的良效，快速得到满意的治疗效果 。
3.EM原露消炎杀菌，除腥臭异味，防腐保鲜，分解有毒有害物质，促进伤口快速愈合，明显增强胃肠抗击疾病功能。沙蒿籽作为稳定粘结剂，也有祛风除湿，清热解毒消肿的功效。诸物合用能发挥相互相生良效，扶正祛邪，一物多用，极大地提高药物的功效，提升药物的品质。
4.采用的中草药物无毒，安全可靠，内服外用针对性治疗瘀血肿痛，痈疮肿毒，肿囊瘤等病症，疗效显著，使用方便简单易行。
具体实施方式
实施例1
一种散瘀消肿的药物，采用原料为：香茶菜40克、白芍40克、牛筋草25克、黄花倒水莲30克、平地木20克、玄精石16克、沙蒿籽适量、EM原露按需使用。
将香茶菜、白芍、牛筋草、玄精石、黄花倒水莲和平地木筛选、净化，粉碎，放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬25-40分钟。
打开锅盖滤出药汁，晾凉至常温后加入适量EM原露拌匀，即成为清热利湿，活血散瘀消肿的内服药物。
将药渣倒在陶瓷盘中，在常温下加入适量沙蒿籽和适量EM原露拌匀，成为清热利湿，活血散瘀消肿的外用药物。
实施例2
一种散瘀消肿的药物，采用原料为：香茶菜75克、白芍75克、牛筋草45克、黄花倒水莲55克、平地木35克、玄精石35克、沙蒿籽适量、EM原露按需使用。
将香茶菜、白芍、牛筋草、玄精石、黄花倒水莲和平地木筛选、净化，粉碎，放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬25-40分钟。
打开锅盖滤出药汁，晾凉至常温后加入适量EM原露拌匀，即成为清热利湿，活血散瘀消肿的内服药物。
将药渣倒在陶瓷盘中，在常温下加入适量沙蒿籽和适量EM原露拌匀，成为清热利湿，活血散瘀消肿的外用药物。
实施例3
一种散瘀消肿的药物，采用原料为：香茶菜120克、白芍120克、牛筋草70克、黄花倒水莲80克、平地木60克、玄精石50克、沙蒿籽适量、EM原露按需使用。
将香茶菜、白芍、牛筋草、玄精石、黄花倒水莲和平地木筛选、净化，粉碎，放入陶瓷锅中，加入适量水，武火烧沸后改文火慢熬25-40分钟。
打开锅盖滤出药汁，晾凉至常温后加入适量EM原露拌匀，即成为清热利湿，活血散瘀消肿的内服药物。
将药渣倒在陶瓷盘中，在常温下加入适量沙蒿籽和适量EM原露拌匀，成为清热利湿，活血散瘀消肿的外用药物。
使用方法：内服—每天1-2次， 1周为1个疗程。外用—每天1-2次， 1周为1个疗程，常温药渣敷贴患部。 注：孕妇勿用。
其中，部分原料的功效及作用如下：
香茶菜：又名山薄荷、小叶蛇总管。味辛、苦，性凉。归肝、肾经。功能清热利湿，活血散瘀，解毒消肿。主治湿热黄疸，淋证，水肿，咽喉肿痛，关节痹痛，闭经，乳痈，痔疮，发背，跌打损伤，毒蛇咬伤。还可治扁桃体炎、急性传染性肝炎、关节痛、淋巴腺炎、沁尿道感染、中暑腹痛、胃痛、癌症疼痛。经药理研究有抗炎、抗菌、抗肿瘤作用及对肝损伤的保护作用。
白芍：又名白芍药、金芍药，苦、酸，微寒。归肝、脾经。功用养血和营，缓急止痛，敛阴平肝。主治血虚寒热，脘腹疼痛，胁痛，肢体痉挛疼痛，痛经，月经不调，崩漏，自汗，盗汗，下痢泄泻，头痛眩晕。主通顺血脉，除血痹，缓中，益好血。
牛筋草：又名千金草、穇子草等。味甘、淡，凉，入肝经。功用清热解毒，利湿，凉血散瘀。主治伤暑发热，小儿惊风，乙脑，流脑，黄疸，淋证，小便不利，痢疾，便血，疮疡肿痛，荨麻疹，跌打损伤。活血补气，行血长力，强筋骨，治遗精，驱风利湿，散瘀止血。
黄花倒水莲：又名观音串、黄花远志。味甘、微苦、平。归脾、肾经。功用补气血，强筋骨，通经络。主治劳倦乏力，脾虚水肿，肾虚腰痛，阳痿，带下，风湿痹痛，月经不调，痛经，跌打损伤。黄花倒水莲滋补强壮，散瘀消肿，补脾益肾，滋阴降火，还治产后腰痛，子宫脱垂，小儿疳积，遣尿。
平地木：又名叶下红、雪里珠、铺地凉伞。辛、微苦、平，归肺、肝经。功用化痰止咳，利湿，活血。主治新久咳嗽，黄疸，水肿，淋证，白带，经闭，痛经，风湿痹痛，跌打损伤，咯血，吐血。
玄精石：又名太阴玄精、玄英石，味咸、性寒，归肾经。功能清热，明目，消痰。主治阳盛阴虚，壮热烦渴，头风脑痛，目赤涩痛，翳障遮精，重舌木舌，头疮，水火烫伤。除风冷邪气湿痹，益精气，妇人痼冷漏下，心腹积聚冷气，止头疼，解肌。
EM原露：属酸性，EM原露是微生物益菌剂，有广泛的优良作用，可以消炎杀菌，除腥臭异味，防腐保鲜，分解有毒有害物质，还帮助动物植物消除病害健康生长，人们可以内服外用，防病治病优点多不胜数。EM原露是良性的功能菌群体，在众多领域所具有特殊的功能可以为其提供必要的服务。用于家庭及人体保健：治疗消化系统，循环系统及癌症、风湿、类风湿、妇科病、外科等疾病，也可用于消炎、治疗烫伤、促进伤口快速愈合等。内服或外擦，见效。可用于蔬菜、水果保鲜、清洗及去污等。
沙蒿籽：又名黑沙蒿籽。是生长在内蒙古沙漠地区的黑沙蒿植物的沙蒿籽。味辛、苦，性微温，无毒。经长期应用经验，其沙蒿籽也有祛风除湿，清热解毒消肿的功效。沙蒿籽的主要成分由D-葡萄糖、D-甘露醇、D-半乳糖、L-阿拉伯糖和木糖组成的一种具有交联结构的多糖类物质。粘度大（1%溶液达900Pa.s）为明胶的1800倍，不溶于水，但可均匀分散于水，吸水数十倍后溶胀成蛋清样胶体。可作食品增稠剂、保水剂、稳定剂和面团调节剂。
临床应用：住宅区里有6位关节炎、腰腿痛的病患者，他们使用本申请的药物内服外用治疗，经3个多疗程使用后，2位关节炎患者发热红肿现象消失，能屈能伸自如，痊愈。1位腿痛的患者走路十分轻松，以前沉重、屈伸不利的现象消失，痊愈。1位腰酸背痛的患者也能挺起腰板走路，提物品有劲了，其余的患者也有不同程度好转，还继续使用药物。其中有2位小孩子因患扁桃体炎，减少药量给孩子食用，痊愈。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等，均应包含在本发明的保护范围之内。
Claims (4)
1.一种散瘀消肿的药物，其特征在于，采用原料为：香茶菜40-120克、白芍40-120克、牛筋草25-70克、黄花倒水莲30-80克、平地木20-60克、玄精石16-50克、沙蒿籽适量、EM原露按需使用，
将香茶菜、白芍、牛筋草、玄精石、黄花倒水莲和平地木筛选、净化，粉碎，放入陶瓷锅中，加入水，武火烧沸后改文火慢熬25-40分钟，
打开锅盖滤出药汁，晾凉至常温后加入EM原露拌匀，即成为清热利湿，活血散瘀消肿的内服药物，
将药渣倒在陶瓷盘中，在常温下加入沙蒿籽和EM原露拌匀，成为清热利湿，活血散瘀消肿的外用药物。
2.根据权利要求1所述一种散瘀消肿的药物，其特征在于，采用原料为：香茶菜40克、白芍40克、牛筋草25克、黄花倒水莲30克、平地木20克、玄精石16克、沙蒿籽适量、EM原露按需使用。
3.根据权利要求1所述一种散瘀消肿的药物，其特征在于，采用原料为：香茶菜75克、白芍75克、牛筋草45克、黄花倒水莲55克、平地木35克、玄精石35克、沙蒿籽适量、EM原露按需使用。
4.根据权利要求1所述一种散瘀消肿的药物，其特征在于，采用原料为：香茶菜120克、白芍120克、牛筋草70克、黄花倒水莲80克、平地木60克、玄精石50克、沙蒿籽适量、EM原露按需使用。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610577885.0A CN106110011A (zh) | 2016-07-21 | 2016-07-21 | 一种散瘀消肿的药物 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610577885.0A CN106110011A (zh) | 2016-07-21 | 2016-07-21 | 一种散瘀消肿的药物 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106110011A true CN106110011A (zh) | 2016-11-16 |
Family
ID=57289315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610577885.0A Withdrawn CN106110011A (zh) | 2016-07-21 | 2016-07-21 | 一种散瘀消肿的药物 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106110011A (zh) |
-
2016
- 2016-07-21 CN CN201610577885.0A patent/CN106110011A/zh not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106309611A (zh) | 一种通筋活血膏药 | |
| CN105687409A (zh) | 一种砭石泥灸及其制备方法 | |
| CN103071016B (zh) | 治疗骨关节病及其软组织损伤的外用中药膏 | |
| CN103736069A (zh) | 一种治疗风湿病的膏药及其制备方法 | |
| CN103330872B (zh) | 一种蛇伤康复药的制备方法 | |
| WO2016066058A1 (zh) | 一种治疗乳腺炎的外敷中药组合物 | |
| CN104208635A (zh) | 一种用于缓解疼痛的外用中药组合物及其制备方法 | |
| CN104474152A (zh) | 一种宜于逐瘀生新的药物 | |
| CN106177576A (zh) | 一种治疗前列腺增生的中药及其制备方法 | |
| CN104825598A (zh) | 一种治疗风湿骨痛的外用膏药及其制备方法 | |
| CN106110011A (zh) | 一种散瘀消肿的药物 | |
| CN104524107A (zh) | 用于风寒湿痹证的中成药 | |
| CN104474153A (zh) | 用于消炎止痛散瘀生肌的药物 | |
| CN104189477A (zh) | 一种治疗脚气的中药配方 | |
| CN103251779B (zh) | 专治猪冻伤的中药药膏 | |
| CN106266704A (zh) | 治疗肠胃炎的中药组合物及制备方法 | |
| CN105796796A (zh) | 一种活血化瘀的外用膏药及其制作方法 | |
| CN106214902A (zh) | 一种治疗急性咽炎的中药 | |
| CN105343771A (zh) | 一种治疗颈椎腰椎退行性病变的新型中药及制备工艺 | |
| CN104523868A (zh) | 一种治疗瘀血痹阻证的药物 | |
| CN104645196A (zh) | 一种治疗癌痛的中药配方 | |
| CN103638411B (zh) | 一种治疗淋巴结核的药物及其制备方法 | |
| CN102106954A (zh) | 一种治疗冻疮的中药组方 | |
| CN105998206A (zh) | 一种散瘀消肿的药物 | |
| CN103211986B (zh) | 一种治疗湿热下注型肛门湿疹的中药 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20161116 |
|
| WW01 | Invention patent application withdrawn after publication |